/Investor DB

re.Mind Capital

Venture capitaloperating company · company profile

London · Pre-Seed–Series A · 2 people tracked

Find your way into re.Mind Capital

Each arrow is one introduction. Sign up to fill in the first one.

1,059 people can intro you to Max

Ask Christian Angermayer to introduce you to Max de Vere

You →Christian · together at Apeiron Investment Group →Max

85 people can intro you to Joao

Ask Jamie Chen to introduce you to Joao Barbosa da Silva

You →Jamie · together at re.Mind Capital →Joao

Sign up to find every way you can get introduced to re.Mind Capital

  • Your email: who you already know at re.Mind Capital, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the re.Mind Capital team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

An early-stage venture capital firm focused exclusively on investing in mental health, brain health, and human flourishing companies.

Source: firm website, verified Sep 27, 2026.

Stage
Pre-Seed–Series A
HQ
London, GB
Instruments
Equity
Tracked investments
8
Unicorns
1
IPOs
1

Team · 2 people

from public directories
Max de Vere· Investorin

What they invest in

from 6 of 8 portfolio companies

Biotech ×4Digital Health ×4Medical Devices ×4Deep Tech ×3Healthtech ×2AI & Machine Learning ×1Enterprise Software ×1SaaS ×1

HQs:United States×6

Investments · 8 tracked

founders shown can be your intro path

By year:2024 · 22023 · 12021 · 58 dated

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRAOct 2021

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+11 more

Anna Healthannaautismcare.comNov 2024 · $9M

ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching.

Digital HealthHealthtechWellness & FitnessBoston, US

Aimun Malik(Executive Officer, Director, Promoter)

BoardBinoy Bhansali(Director)Sean Doolan(Director)in

Co-investorsGreyMatterMute VenturesVirtue Ventures

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsArtis VenturesBailey Venture PartnersCasa Verde CapitalDolby Family VenturesNoeticOMX Ventures+6 more

Ksana Healthksanahealth.cominJun 2021

Active seed-stage healthcare company

Eugene, US

Nicholas Allen(Chief Executive Officer)Phillip Scripa(Chief Financial Officer and Secretary)William Shortt(Chief Operating Officer)Jan Hardorp(Director)in

Co-investorsBIP VenturesJLSPalo Santo VC

Motif Neurotechmotifneuro.techin𝕏Jan 2024 · $19M

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)

Co-investorsArboretum VenturesDivergent CapitalDolby Family VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture Fund+6 more

Precisionprecision.co𝕏Jan 2023 · $41M

Precision is an AI platform paired with operators who build, train, and run AI agents across a company's marketing, delivery, support, operations, and finance functions.

AI & Machine LearningEnterprise SoftwareSaaS

Matt Verlaque(Founder)in

Co-investorsRevUp Capital216 CapitalAlumni VenturesB CapitalB Capital GroupDraper Associates+3 more

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Founder)inThomas Oxley(Founder)inTom Oxley(Founder)

BoardRahul Sharma(Director)Alex Morgan(Director)in

Co-investorsAlumni VenturesARCH Venture PartnersForepont Capital PartnersID8 InvestmentsK2 GlobalKaleida Capital+15 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Blackrock Microsystems

Exits · 1

1 IPOs

Neumora TherapeuticsNASDAQ: NMRA

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has re.Mind Capital made?
re.Mind Capital has 8 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does re.Mind Capital invest at?
re.Mind Capital invests at the Pre-Seed, Seed, Series A stages.
What sectors does re.Mind Capital focus on?
re.Mind Capital focuses on Digital Health, Healthtech, Mental Health, Wellness & Fitness.
Where is re.Mind Capital located?
re.Mind Capital is headquartered in London, GB.

Co-investors · 3

Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

Both backed · 1
$500K – $5M
What If Ventures

What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

Firms observed investing alongside re.Mind Capital, from public investor directories. Shared companies are the overlap with re.Mind Capital's recorded portfolio.

Similar investors

Featured in lists